Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ADD. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110437212A reveals efficient copper-catalyzed synthesis. Delivers high-purity intermediates with substantial cost reduction and supply chain reliability.
Advanced chemical resolution process for L-Valine and D-Valine using DBTA. Delivers >98% optical purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN101885924B details a novel benzotriazole dye synthesis extending absorption to over 400nm, offering cost-effective visible light photoinitiator solutions for industrial curing applications.
Novel stereospecific synthesis of picropodophyllin intermediates via isoxazole cycloaddition. Enhances purity and scalability for antineoplastic API manufacturing.
Novel biocatalytic route for Hydroxytyrosol using polyphenol oxidase and ascorbic acid inhibition ensures high purity and scalable production for pharmaceutical intermediates.
Novel antioxidant-catalyzed route for 2-mercaptobenzimidazole. Yields exceed 99%. Zero wastewater discharge. Ideal for rubber additives and pharma intermediates.
Patent CN109748841B details a metal-free organocatalytic route for chiral beta-aminoketones. This method offers high enantioselectivity and cost reduction in API manufacturing.
Patent CN111763703B reveals a novel DMF-based enzymatic route for sucrose-6-ethyl ester, offering higher yields and greener processing for reliable sweetener intermediate supply chains.
Patent CN101899484B details a novel co-immobilization method for genipin production, offering high purity, extended enzyme stability, and significant cost reductions for supply chains.
Advanced synthesis of 3,3'-dimethyl-4,4'-biphenyldiol via green two-step method. Delivers 99.9% purity for liquid crystal polymers with reduced environmental impact.
Novel dihydroorotase method for alpha-aspartyl peptides. Reduces racemization, simplifies purification. Ideal for sweetener and pharma intermediate manufacturing.
Patent CN1298860C reveals enzymatic conversion for high-purity GABA. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN101717372B details a cost-effective synthesis for benzotriazole UV absorber intermediates, offering simplified steps and high purity for coating and polymer applications.
Novel silver-catalyzed radical oxidative addition for polysubstituted pyrroles. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN1062604C details enzymatic DL-Methionine resolution. Achieves high yield and purity. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN114516835B reveals mild oxidation cascade for high purity intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Novel liquid-liquid two-phase method reduces DMF decomposition and boosts yield for sucralose-6-acetate. Cost-effective and scalable manufacturing solution for global supply chains.
Novel low-temperature synthesis for DiDOPO-A reduces corrosion and cost. Reliable supply chain for high-purity flame retardant intermediates with scalable production capacity.
Patent CN103058831A discloses novel diphenolic acid derivatives preparation. Offers cost-effective routes for epoxy resins and polycarbonates with high purity.
Patent CN111825681A reveals a metal-free one-pot route for spiro compounds, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.